Q2 2021 EPS Estimates for Teleflex Incorporated Cut by Analyst (NYSE:TFX)


Share on StockTwits

Teleflex Incorporated (NYSE:TFX) – Analysts at Piper Sandler reduced their Q2 2021 earnings per share estimates for Teleflex in a report released on Thursday, April 29th. Piper Sandler analyst M. O’brien now expects that the medical technology company will earn $2.90 per share for the quarter, down from their prior forecast of $3.07. Piper Sandler has a “Overweight” rating and a $465.00 price target on the stock. Piper Sandler also issued estimates for Teleflex’s Q2 2022 earnings at $3.41 EPS.

A number of other equities analysts have also issued reports on the company. Needham & Company LLC upped their target price on Teleflex from $406.00 to $445.00 and gave the company a “buy” rating in a research report on Wednesday, January 6th. Morgan Stanley upped their price target on Teleflex from $450.00 to $478.00 and gave the company an “overweight” rating in a research report on Friday, April 30th. Wells Fargo & Company upped their price target on Teleflex from $425.00 to $455.00 and gave the company an “overweight” rating in a research report on Monday, January 11th. Raymond James upped their price target on Teleflex from $460.00 to $480.00 and gave the company a “strong-buy” rating in a research report on Thursday, March 18th. Finally, SVB Leerink upped their price target on Teleflex from $475.00 to $485.00 and gave the company an “outperform” rating in a research report on Friday, April 30th. Eight research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of $460.44.

Shares of TFX opened at $412.68 on Monday. The business’s 50 day moving average is $422.17 and its two-hundred day moving average is $394.45. Teleflex has a 52-week low of $312.33 and a 52-week high of $449.38. The firm has a market cap of $19.29 billion, a price-to-earnings ratio of 53.11, a PEG ratio of 2.63 and a beta of 1.14. The company has a quick ratio of 1.88, a current ratio of 2.99 and a debt-to-equity ratio of 0.63.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, April 29th. The medical technology company reported $2.87 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.44 by $0.43. Teleflex had a return on equity of 16.33% and a net margin of 14.66%.

A number of institutional investors and hedge funds have recently modified their holdings of the stock. BlackRock Inc. grew its stake in Teleflex by 1.2% during the 4th quarter. BlackRock Inc. now owns 4,976,722 shares of the medical technology company’s stock worth $2,048,269,000 after buying an additional 57,557 shares during the last quarter. Janus Henderson Group PLC grew its stake in Teleflex by 9.2% during the 4th quarter. Janus Henderson Group PLC now owns 908,221 shares of the medical technology company’s stock worth $373,797,000 after buying an additional 76,395 shares during the last quarter. Bank of New York Mellon Corp grew its stake in Teleflex by 6.1% during the 4th quarter. Bank of New York Mellon Corp now owns 643,615 shares of the medical technology company’s stock worth $264,891,000 after buying an additional 36,730 shares during the last quarter. Parnassus Investments CA grew its stake in shares of Teleflex by 1.4% in the fourth quarter. Parnassus Investments CA now owns 549,746 shares of the medical technology company’s stock worth $226,259,000 after purchasing an additional 7,554 shares in the last quarter. Finally, DF Dent & Co. Inc. grew its stake in shares of Teleflex by 15.3% in the fourth quarter. DF Dent & Co. Inc. now owns 532,568 shares of the medical technology company’s stock worth $219,189,000 after purchasing an additional 70,840 shares in the last quarter. Hedge funds and other institutional investors own 89.78% of the company’s stock.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 15th. Investors of record on Friday, May 14th will be paid a dividend of $0.34 per share. The ex-dividend date of this dividend is Thursday, May 13th. This represents a $1.36 dividend on an annualized basis and a yield of 0.33%. Teleflex’s payout ratio is currently 12.20%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading: What is the role of the G-20?

Earnings History and Estimates for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.